23andMe Holding Co.
Change company Symbol lookup
Select an option...
ME 23andMe Holding Co.
UZAPF Flughafen Zuerich AG
SLVO Credit Suisse X-Links Silver Shares Covered Call ETN
ARQQ Arqit Quantum Inc
MA Mastercard Inc
BEN Franklin Resources Inc
REGN Regeneron Pharmaceuticals Inc
PSNL Personalis Inc
CORR CorEnergy Infrastructure Trust Inc
SBRA Sabra Health Care REIT Inc
Go

Company profile

23andMe Holding Co., formerly VG Acquisition Corp., is a consumer genetics and research company. The Company offers direct-to-consumer genetic testing and personalized information about genetic health risks, ancestry, and traits. The Company operates through two segments: Consumer & Research Services and Therapeutics. Its consumer & research services business segment comprises personal genome service (PGS) and research services. Its PGS provides a suite of genetic reports, including information on genetic ancestral origins, personal genetic health risks, rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications. The Company’s therapeutics segment focuses on drug development for discovering and developing therapies to improve patient lives and includes out-licensing of intellectual property. The Company’s programs across therapeutic areas, include oncology, immunology, neurology, metabolic and cardiovascular diseases.

Postmarket

Last Trade
Delayed
$4.81
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$4.81
Day's Change
-0.03 (-0.62%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
5.06
Day's Low
4.73
Volume
(Below Average)
Volume:
3,020,312

10-day average volume:
3,395,399
3,020,312

Teladoc Health to Host Investor Day on November 18, 2021

8:16 am ET November 2, 2021 (Globe Newswire) Print

Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that it will host its Investor Day on Thursday, November 18, 2021.

Members of Teladoc Health's senior management team will join Jason Gorevic, chief executive officer and Mala Murthy, chief financial officer, for the half day program which will offer key insights about the industry's evolution and rapid growth as well as the company's vision, strategy, and outlook.

Teladoc Health's Investor Day will be accessible via a live audio webcast that will be available at https://ir.teladochealth.com/news-and-events/events-and-presentations/. A replay will be available via webcast for on-demand listening shortly after the completion of the meeting, at the same web link, and will remain available for approximately 90 days.

About Teladoc Health

Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person's health journey. Ranked best in KLAS for Virtual Care Platforms in 2020 and #1 among direct-to-consumer telehealth providers in the J.D. Power 2021 U.S. Telehealth Satisfaction Study, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals. For more information, please visit www.teladochealth.com or follow @TeladocHealth on Twitter.

Investors:

Patrick Feeley

914-265-7925

IR@teladochealth.com

https://ml.globenewswire.com/media/af93f081-236b-439f-a691-098fc0a8649e/small/teladochealth-logo-plum-aqua-rgb-1-png.png

https://ml.globenewswire.com/media/af93f081-236b-439f-a691-098fc0a8649e/small/teladochealth-logo-plum-aqua-rgb-1-png.png

comtex tracking

COMTEX_396225186/2010/2021-11-02T08:16:40

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.